Related Experiment Video
Updated: Jul 2, 2026
07:30
Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
Oscillatory control of insulin secretion
1Department of Medical Cell Biology, Uppsala University, Biomedical Centre, Box 571, SE-75123 Uppsala, Sweden. anders.tengholm@mcb.uu.se
Molecular and Cellular Endocrinology
|August 19, 2008
Summary
Pancreatic beta-cells generate oscillatory signals for insulin release. These oscillations, involving calcium and metabolism, are key for pulsatile insulin secretion and may offer targets for type 2 diabetes treatment.
Area of Science:
- Endocrinology
- Cell Biology
- Metabolic Research
Background:
- Pancreatic beta-cells are crucial for glucose homeostasis through insulin secretion.
- Coordinated beta-cell activity leads to pulsatile insulin release, vital for hormone efficacy.
- Dysregulation of pulsatile insulin secretion is implicated in type 2 diabetes.
Purpose of the Study:
- To review the mechanisms controlling insulin secretion oscillations at the single beta-cell level.
- To explore the interplay between various signaling pathways regulating insulin secretion.
- To identify potential therapeutic targets for enhancing pulsatile insulin secretion in type 2 diabetes.
Main Methods:
- Review of recent scientific literature on beta-cell signaling and insulin secretion.
- Analysis of studies investigating calcium, metabolic, and cAMP oscillations.
- Examination of the role of phospholipase C and phosphoinositide lipids.
Main Results:
- Cytoplasmic Ca(2+) oscillations are synchronized with metabolic and cAMP oscillations in beta-cells.
- Complex interdependencies exist between signaling pathways controlling insulin secretion.
- These pathways regulate the amplitude and shape of the insulin secretory response.
Conclusions:
- Oscillatory signaling is fundamental to regulated insulin release from beta-cells.
- Interconnected signaling networks fine-tune insulin secretion dynamics.
- Targeting these oscillatory mechanisms presents a promising strategy for type 2 diabetes therapy.
More Related Videos
Related Concept Videos
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:05Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:01Feedback Loops
In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...